Main outcome events during follow-up in 891 WHO-ET patients
| . | No. . | % . | Rate, % patient-years (95% CI) . |
|---|---|---|---|
| Patients with nonfatal thrombotic events | 109 | 12 | 1.7 (1.4-2.1) |
| Arterial | 79 | 9 | 1.2 (1.0-1.5) |
| AMI | 17 | 2 | 0.26 (0.16-0.42) |
| Stroke-TIA | 47 | 5 | 0.73 (0.54-0.97) |
| PAT | 15 | 2 | 0.23 (0.14-0.38) |
| Venous (VTE) | 37 | 4 | 0.6 (0.4-0.8) |
| Patients with fatal and nonfatal thrombotic events | 119 | 13 | 1.9 (1.6-2.3) |
| . | No. . | % . | Rate, % patient-years (95% CI) . |
|---|---|---|---|
| Patients with nonfatal thrombotic events | 109 | 12 | 1.7 (1.4-2.1) |
| Arterial | 79 | 9 | 1.2 (1.0-1.5) |
| AMI | 17 | 2 | 0.26 (0.16-0.42) |
| Stroke-TIA | 47 | 5 | 0.73 (0.54-0.97) |
| PAT | 15 | 2 | 0.23 (0.14-0.38) |
| Venous (VTE) | 37 | 4 | 0.6 (0.4-0.8) |
| Patients with fatal and nonfatal thrombotic events | 119 | 13 | 1.9 (1.6-2.3) |
AMI indicates acute myocardial infarction; TIA, cerebral transient ischemic attack; PAT, peripheral arterial thrombosis; and VTE, venous thromboembolism.